IntegerBio
IntegerBio is at the forefront of Immunovirology, committed to combating serious viral diseases by pioneering the intersection of immunology and virology. The company focuses on developing broad multi-viral therapeutics using cutting-edge biology and data-focused approaches. Their mission is to harness the power of science to design therapeutics with durable responses across multiple viruses, aiming for a future without the fear of viral disease.
IntegerBio
What We Do
SYNFERON™ molecules are synthetic proteins designed to target Interferon-alpha receptors, IFNAR1 and IFNAR2, to synergize pathways of the immune system. They are developed to program the Type I Interferon pathway for potent multi-viral activity while minimizing inflammation and reducing side effects.